glp-1 agonists reduce inflammation receptor show evidence of reducing #Psoriasis severity and systemic in patients with #obesity or #diabetes, with a favorable safety profile and compatibility with standard therapies. https://t.co/aMBllABaVT Glucagon-like peptide 1 receptor agonists:

Dang et al

[PubMed: 17322494] 234

( a ) Fasting plasma GIP (CON n = 11, Gipr AP-KO n = 12), ( b ) total GLP-1 (CON n = 11, Gipr AP-KO n = 12) ( c ) insulin (CON n = 11, Gipr AP-KO n = 12), ( d ) food intake post IPGTT, ( e ) ad lib fed blood glucose, ( f ) RER, ( g ) energy expenditure (inset, with ANCOVA using BW as covariate), ( h ) ambulatory activity (x beam breaks) of std chow fed (lean) mice ( d - h : CON n = 11, Gipr AP-KO n = 13, symbols as defined in f)

Chicago Greenwood, Michael

Recent in vivo studies have shown that chlorella can successfully bind significant percentages of dangerous mycotoxins like Deoxynivalenol (DON) and Ochratoxin A (OTA) directly within the gut, preventing their absorption into the blood plasma